LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.62 | 770.25 | 1515 | 2514 | 0.6024 | 0.4863 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.62 | 770.25 | 1425 | 2514 | 0.5666 | 0.4339 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.84 | 770.25 | 1499 | 2833 | 0.5290 | 0.4252 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.84 | 770.25 | 1430 | 2833 | 0.5046 | 0.3899 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 30.06 | 770.25 | 1525 | 3106 | 0.4910 | 0.4043 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 30.06 | 770.25 | 1419 | 3106 | 0.4568 | 0.3549 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 32.28 | 770.25 | 1513 | 3392 | 0.4459 | 0.3711 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 32.28 | 770.25 | 1449 | 3392 | 0.4271 | 0.3437 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.50 | 770.25 | 1501 | 3712 | 0.4044 | 0.3419 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.50 | 770.25 | 1453 | 3712 | 0.3914 | 0.3228 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.73 | 770.25 | 1503 | 4086 | 0.3678 | 0.3201 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.73 | 770.25 | 1449 | 4086 | 0.3546 | 0.3002 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.95 | 770.25 | 1507 | 4543 | 0.3317 | 0.2997 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.95 | 770.25 | 1458 | 4543 | 0.3209 | 0.2830 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.17 | 770.25 | 1505 | 5010 | 0.3004 | 0.2814 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.17 | 770.25 | 1489 | 5010 | 0.2972 | 0.2763 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.39 | 770.25 | 1515 | 5404 | 0.2803 | 0.2721 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.39 | 770.25 | 1507 | 5404 | 0.2789 | 0.2697 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.61 | 770.25 | 1544 | 5813 | 0.2656 | 0.2693 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.61 | 770.25 | 1541 | 5813 | 0.2651 | 0.2685 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.83 | 770.25 | 1576 | 6223 | 0.2532 | 0.2681 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.83 | 770.25 | 1568 | 6223 | 0.2520 | 0.2660 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 50.05 | 770.25 | 1595 | 6629 | 0.2406 | 0.2641 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 50.05 | 770.25 | 1596 | 6629 | 0.2407 | 0.2644 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 52.27 | 770.25 | 1627 | 7058 | 0.2305 | 0.2636 | MN20160304_L02 | C04 |